| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in Stem Cell Transplantation: Making it Better and Safer
|
Giralt, Sergio
|
|
2009
|
|
S3 |
p. S293-S295
3 p.
|
artikel
|
| 2 |
Allogeneic Hematopoietic Progenitor Cell Transplantation for the Treatment of Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors: Lessons Learned to Date
|
Giralt, Sergio
|
|
2007
|
|
S3 |
p. S102-S104
3 p.
|
artikel
|
| 3 |
Bcr-Abl Kinase Domain Mutations and the Unsettled Problem of Bcr-AblT315I: Looking into the Future of Controlling Drug Resistance in Chronic Myeloid Leukemia
|
O'Hare, Thomas
|
|
2007
|
|
S3 |
p. S120-S130
11 p.
|
artikel
|
| 4 |
Burkitt Lymphoma/Leukemia: Improving Prognosis
|
Kenkre, Vaishalee P.
|
|
2009
|
|
S3 |
p. S231-S238
8 p.
|
artikel
|
| 5 |
Chronic Myeloid Leukemia: Current Management Challenges
|
Mughal, Tariq
|
|
2007
|
|
S3 |
p. S94-
1 p.
|
artikel
|
| 6 |
Efficacy of Various Doses and Schedules of Second-Generation Tyrosine Kinase Inhibitors
|
Bixby, Dale L.
|
|
2008
|
|
S3 |
p. S95-S106
12 p.
|
artikel
|
| 7 |
Emerging Safety Issues with Imatinib and Other Abl Tyrosine Kinase Inhibitors
|
Atallah, Ehab
|
|
2007
|
|
S3 |
p. S105-S112
8 p.
|
artikel
|
| 8 |
Familial Chronic Lymphocytic Leukemia: What Does it Mean to Me?
|
Slager, Susan L.
|
|
2009
|
|
S3 |
p. S194-S197
4 p.
|
artikel
|
| 9 |
Flavopiridol in Chronic Lymphocytic Leukemia: A Concise Review
|
Christian, Beth A.
|
|
2009
|
|
S3 |
p. S179-S185
7 p.
|
artikel
|
| 10 |
Hairy Cell Leukemia
|
Ravandi, Farhad
|
|
2009
|
|
S3 |
p. S254-S259
6 p.
|
artikel
|
| 11 |
High-Risk Childhood Acute Lymphoblastic Leukemia
|
Bhojwani, Deepa
|
|
2009
|
|
S3 |
p. S222-S230
9 p.
|
artikel
|
| 12 |
JAK2 Inhibitors: A Reality? A Hope?
|
Apostolidou, Effrosyni
|
|
2009
|
|
S3 |
p. S340-S345
6 p.
|
artikel
|
| 13 |
Lenalidomide—A Transforming Therapeutic Agent in Myelodysplastic Syndromes
|
List, Alan
|
|
2009
|
|
S3 |
p. S302-S304
3 p.
|
artikel
|
| 14 |
Measuring Minimal Residual Disease in Chronic Myeloid Leukemia: Fluorescence In Situ Hybridization and Polymerase Chain Reaction
|
Hughes, Timothy P.
|
|
2009
|
|
S3 |
p. S266-S271
6 p.
|
artikel
|
| 15 |
Minimal Residual Disease Quantitation in Acute Myeloid Leukemia
|
Shook, David
|
|
2009
|
|
S3 |
p. S281-S285
5 p.
|
artikel
|
| 16 |
Molecular and Genetic Bases of Myeloproliferative Disorders: Questions and Perspectives
|
Plo, Isabelle
|
|
2009
|
|
S3 |
p. S329-S339
11 p.
|
artikel
|
| 17 |
Never Say Die: Survival Signaling in Large Granular Lymphocyte Leukemia
|
Shah, Mithun Vinod
|
|
2009
|
|
S3 |
p. S244-S253
10 p.
|
artikel
|
| 18 |
New Strategies for the First-Line Treatment of Chronic Myeloid Leukemia: Can Resistance Be Avoided?
|
Snead, Jennifer L.
|
|
2008
|
|
S3 |
p. S107-S117
11 p.
|
artikel
|
| 19 |
New Thrombopoietic Growth Factors
|
Kuter, David J.
|
|
2009
|
|
S3 |
p. S347-S356
10 p.
|
artikel
|
| 20 |
Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era
|
Champlin, Richard
|
|
2009
|
|
S3 |
p. S261-S265
5 p.
|
artikel
|
| 21 |
Novel Abl Kinase Inhibitors in Chronic Myeloid Leukemia in Blastic Phase and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|
Swords, Ronan
|
|
2007
|
|
S3 |
p. S113-S119
7 p.
|
artikel
|
| 22 |
Optimal Management of Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia in 2007
|
Mughal, Tariq
|
|
2007
|
|
S3 |
p. S95-S101
7 p.
|
artikel
|
| 23 |
Optimizing Timing of Secondary Tyrosine Kinase Therapy in Chronic Myeloid Leukemia
|
Radich, Jerald P.
|
|
2008
|
|
S3 |
p. S89-S94
6 p.
|
artikel
|
| 24 |
Optimizing Treatment with Bcr-Abl Tyrosine Kinase Inhibitors in Philadelphia Chromosome—Positive Chronic Myeloid Leukemia: Focus on Dosing Schedules
|
Jabbour, Elias
|
|
2008
|
|
S3 |
p. S75-S81
7 p.
|
artikel
|
| 25 |
Practical Management of Toxicities Associated with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
|
Quintás-Cardama, Alfonso
|
|
2008
|
|
S3 |
p. S82-S88
7 p.
|
artikel
|
| 26 |
Progress in Myelodysplastic Syndromes
|
Garcia-Manero, Guillermo
|
|
2009
|
|
S3 |
p. S286-S292
7 p.
|
artikel
|
| 27 |
Red Bood Cell Transfusion Therapy and Iron Chelation in Patients With Myelodysplastic Syndromes
|
Malcovati, Luca
|
|
2009
|
|
S3 |
p. S305-S311
7 p.
|
artikel
|
| 28 |
RNA Inhibition, MicroRNAs, and New Therapeutic Agents for Cancer Treatment
|
Spizzo, Riccardo
|
|
2009
|
|
S3 |
p. S313-S318
6 p.
|
artikel
|
| 29 |
Second-line Therapy and Beyond Resistance for the Treatment of Patients With Chronic Myeloid Leukemia Post Imatinib Failure
|
Jabbour, Elias
|
|
2009
|
|
S3 |
p. S272-S279
8 p.
|
artikel
|
| 30 |
Stem Cells and Somatic Cells: Reprogramming and Plasticity
|
Estrov, Zeev
|
|
2009
|
|
S3 |
p. S319-S328
10 p.
|
artikel
|
| 31 |
T-Cell Lymphoblastic Lymphoma and T-Cell Acute Lymphoblastic Leukemia: A Separate Entity?
|
Hoelzer, Dieter
|
|
2009
|
|
S3 |
p. S214-S221
8 p.
|
artikel
|
| 32 |
T-Cell Prolymphocytic Leukemia
|
Dearden, Claire E.
|
|
2009
|
|
S3 |
p. S239-S243
5 p.
|
artikel
|
| 33 |
The Antiproliferative Effect of Kefir Cell-Free Fraction on HuT-102 Malignant T Lymphocytes
|
Rizk, Sandra
|
|
2009
|
|
S3 |
p. S198-S203
6 p.
|
artikel
|
| 34 |
The Fine Tuning of Therapy for Chronic Myeloid Leukemia and Upcoming Challenges
|
Talpaz, Moshe
|
|
2008
|
|
S3 |
p. S74-
1 p.
|
artikel
|
| 35 |
Therapeutic Targeting of NOTCH1 Signaling in T-Cell Acute Lymphoblastic Leukemia
|
Palomero, Teresa
|
|
2009
|
|
S3 |
p. S205-S210
6 p.
|
artikel
|
| 36 |
The Use of New and Better Antibiotics for Bacterial Infections in Patients With Leukemia
|
Rolston, Kenneth V.I.
|
|
2009
|
|
S3 |
p. S357-S363
7 p.
|
artikel
|
| 37 |
Transplantation in Chronic Lymphocytic Leukemia: Timing and Expectations
|
Hallam, Simon
|
|
2009
|
|
S3 |
p. S186-S193
8 p.
|
artikel
|
| 38 |
Transplantations in Adult Acute Lymphoblastic Leukemia–Grounds for Optimism?
|
Goldstone, Anthony H.
|
|
2009
|
|
S3 |
p. S211-S213
3 p.
|
artikel
|
| 39 |
What Are the Endpoints of Therapy for Acute Leukemias? Old Definitions and New Challenges
|
Smith, B. Douglas
|
|
2009
|
|
S3 |
p. S296-S301
6 p.
|
artikel
|
Tijdschrift beschrijving